Summary
Machine-generated summarySwansea Bay University Health Board (formerly ABMU Health Board) awarded a contract for the provision of the Oncotype DX Breast Recurrence Score Test for use within Cancer Services. The test provides a genomic-based risk assessment for early-stage invasive breast cancer in the adjuvant setting. It gives information on distant recurrence, the benefit from chemotherapy, and whether a patient can be treated effectively with hormonal therapy alone. NICE has recommended Oncotype in the node negative setting, and local audits suggest its use reduces chemotherapy use by about one third in the target population. The contract was awarded to Exact Sciences Uk, Ltd. on 2026-06-01.
Description
Official source
Source: Sell2Wales (Welsh Government)
Always verify details on the official notice.
Last verified against Sell2Wales (Welsh Government) 1 week ago
More from this buyer
Full buyer profileRecent awards
Similar tenders
Market context
- Avg. open tender · Health & social work
- €39,947,707
- Buyer track record on Aperlena
- 3 notices tracked · 3 awarded
Never miss a tender like this
265 new notices in Health & social work in United Kingdom in the last 7 days. Get an email when new ones appear. Free.
Set up my alert